Hitome

Social Dating Platform

Media & Entertainment Technologies
non_active
Pre-Funding Tel Aviv-Yafo, Israel Founded 2020
LinkedIn
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2020
Headcount
1-10
HQ
Tel Aviv-Yafo, Israel
Sector
Media & Entertainment Technologies

About

Hitome is a social dating platform that powers real-life introductions. The app enables users to introduce each other through friends, match with each other, and find events to attend together. At the events, Hitome's wingman bot introduces singles on the spot. Hitome also produces its own events, with Wingwomen introducing singles live.

Q&A

What is Hitome's primary business?
Hitome is a social dating platform that facilitates real-life introductions by enabling users to introduce each other through friends, match, and find events to attend together. It also uses a 'wingman bot' at events and produces its own events with 'Wingwomen' for live introductions.
When was Hitome founded?
Hitome was founded in February 2020.
What is the current operational status of Hitome?
Hitome is currently non-active and ceased to operate in August 2024.
Who is the founder of Hitome?
The founder of Hitome is Thomas Gouy.
What is Hitome's primary sector?
Hitome's primary sector is Media & Entertainment Technologies.
What technologies does Hitome utilize?
Hitome utilizes Platforms & Interfaces, Mobile, and Artificial Intelligence technologies.
What is Hitome's current funding stage?
Hitome is in the Pre-Funding stage.

Team · 1

Founder · Founder
LinkedIn ↗

Sectors & technology

Primary sector
Media & Entertainment Technologies
Sub-sectors
Media & Entertainment TechnologiesDigital Content Engagement & Entertainment
Technologies
Platforms & InterfacesMobileArtificial Intelligence
Target customers
Media & EntertainmentDating
Business model
B2C

Highlights

Verified

Tags

mobile-applicationssocial-networkslocation-basedartificial-intelligencesocial-platformrecommendationsonline-dating
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)